AstroNova (ALOT) Cash & Equivalents (2010 - 2026)

AstroNova has disclosed Cash & Equivalents across 17 years of filings, most recently posting $4.7 million for Q2 2026.

• In Q2 2026, Cash & Equivalents fell 12.67% year-over-year to $4.7 million; the TTM figure through Apr 2026 stood at $4.7 million (down 12.67% YoY), while the FY2026 annual figure was $4.1 million, down 19.37% from the prior year.
• Cash & Equivalents advanced to $4.7 million in Q2 2026, from $4.1 million in the prior quarter.
• Over the last five years, Cash & Equivalents for ALOT reached as high as $5.8 million in Q2 2022 and fell as low as $3.6 million in Q4 2025.
• The 5-year median for Cash & Equivalents is $4.5 million (2023), against an average of $4.6 million.
• Annual changes were most pronounced in 2022 — Cash & Equivalents sank 62.38% — and 2025, when it surged 34.16%.
• A 5-year view of Cash & Equivalents shows it stood at $4.5 million in 2022, then increased by 7.36% to $4.8 million in 2023, then declined by 8.18% to $4.4 million in 2024, then slipped by 18.64% to $3.6 million in 2025, then gained by 29.65% to $4.7 million in 2026.
• According to Business Quant data, Cash & Equivalents over the past three periods registered $4.7 million, $4.1 million, and $3.6 million for Q2 2026, Q1 2026, and Q4 2025 respectively.